首页 > 市场调查报告书 > 医疗设备

生技设备

晶片器官市场规模、份额和成长分析（按器官类型、模型类型、产品类型、用途、应用、最终用户和地区划分）－2026-2033年产业预测

市场调查报告书

商品编码

1904467

晶片器官市场规模、份额和成长分析（按器官类型、模型类型、产品类型、用途、应用、最终用户和地区划分）－2026-2033年产业预测

Organ on Chip Market Size, Share, and Growth Analysis, By Organ Type (Liver, Kidney), By Model Type, By Product, By Purpose, By Application, By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月23日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，晶片器官市场规模将达到 897.4 亿美元，到 2025 年将成长至 1,173.4 亿美元，到 2033 年将成长至 10,291 亿美元，在预测期（2026-2033 年）内复合年增长率为 30.76%。

受动物实验替代方案的需求以及对药物反应和毒性早期检测的迫切需求驱动，器官晶片市场正经历显着成长。这些微流体装置能够模拟特定器官的功能，进而应用于疾病建模、药物研发和毒性评估等领域。科技的快速进步以及製药、生物技术和学术机构的日益普及，正进一步推动市场成长。此外，随着相关人员探索传统器官以外的新应用领域，并推动器官晶片技术在医疗保健领域的整合，预计该市场将蓬勃发展。尤其是在新冠疫情爆发后，研究能力的提升和对器官晶片技术日益增长的兴趣，预示着该技术将拥有一个充满活力的未来，并将不断涌现创新成果以满足研究界不断变化的需求。

晶片器官市场驱动因素

在全球范围内，反对动物实验的运动日益高涨，这对器官晶片市场产生了重大影响。消费者意识的不断增强，推动了对器官晶片平台的需求成长，这些平台能够促进药物研发、毒性测试及其他相关应用。这些创新技术提供人道、合乎伦理且有效率的解决方案，符合那些呼吁终止动物实验的人们的诉求。随着人们对伦理测试方法的日益关注，器官晶片系统正成为重要的工具，有望改善研究成果，并彻底革新製药和生物医学产业的测试流程。

晶片器官市场的限制因素

由于涉及人体细胞、组织和器官研究的伦理问题，器官晶片市场面临许多限制。知情同意、隐私以及生物材料伦理来源等方面的担忧，使该行业格局变得复杂。必须认真考虑与这项技术相关的法律和社会影响，包括动物福利问题，并在市场中推广负责任的创新和永续实践。解决这些伦理困境对于建立公众信任、确保器官晶片技术的发展符合社会价值和规范至关重要，最终影响其广泛接受度和应用。

晶片器官市场趋势

在製药业成本不断攀升和麵临诸多挑战的背景下，器官晶片市场正呈现出显着的成长趋势，即提高药物安全性和有效性预测的准确性。随着传统方法的限制日益凸显，各公司正加速采用器官晶片技术，以期为药物测试提供更准确、更贴近人体实际的数据。这种创新方法使研究人员能够模拟人体器官对治疗药物的反应，从而提高预测准确性，并显着减少对动物实验的依赖。因此，对先进器官晶片模型的研发投入不断增加，这些模型有望透过简化研发流程和缩短新治疗方法上市时间，彻底革新药物发现过程。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2021-2023年营收年比比较

主要企业简介

Emulate, Inc.
Mimetas BV
Tissuse GmbH
CN Bio Innovations Ltd.
InSphero
Alveolix AG
Fluigent

结论与建议

简介目录

Product Code: SQMIG35A2896

Organ on Chip Market size was valued at USD 89.74 Billion in 2024 and is poised to grow from USD 117.34 Billion in 2025 to USD 1002.91 Billion by 2033, growing at a CAGR of 30.76% during the forecast period (2026-2033).

The organ-on-chip market is experiencing significant growth, driven by the demand for alternatives to animal testing and the urgency for early detection of drug reactions and toxicity. These microfluidic devices replicate specific organ functions, enabling applications in disease modeling, drug development, and toxicity assessment. Rapid technological advancements and increasing adoption across pharmaceuticals, biotech, and academic institutions are further propelling market expansion. Furthermore, as stakeholders explore new applications beyond traditional organs and improve integration into healthcare sectors, the market is expected to flourish. Enhanced research capabilities and the growing interest in organ-on-chip technologies, especially following the Covid-19 pandemic, indicate a robust future, with ongoing innovations anticipated to meet the evolving needs of the research community.

Top-down and bottom-up approaches were used to estimate and validate the size of the Organ on Chip market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Organ on Chip Market Segments Analysis

Global Organ On Chip Market is segmented by organ type, model type, product, purpose, application, end user and region. Based on organ type, the market is segmented into liver, kidney, intestine, lung, heart and other organs. Based on model type, the market is segmented into organ-based models and disease-based models. Based on product, the market is segmented into services and products. Based on purpose, the market is segmented into therapeutics and research. Based on application, the market is segmented into toxicology research, drug discovery, physiological model development, tissue regeneration ®enerative medicineand stem cell research. Based on end user, the market is segmented into pharmaceutical and biotechnology companies, cosmetics industry, academic & research institutes and other end users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Organ on Chip Market

There is a growing global movement advocating for alternatives to animal testing, which significantly impacts the Organ on Chip market. This heightened awareness among consumers is driving an increased demand for organ-on-chip platforms that facilitate drug discovery, toxicity testing, and other related applications. These innovative technologies offer humane, ethical, and efficient solutions that align with the desires of those seeking to eliminate animal experimentation. As the focus on ethical testing methods escalates, organ-on-chip systems are emerging as crucial tools, providing the potential to enhance research outcomes and revolutionize how pharmaceutical and biomedical industries approach testing processes.

Restraints in the Organ on Chip Market

The Organ-on-Chip market faces notable restraints due to ethical considerations related to the utilization of human cells, tissues, and organs in research. Concerns surrounding informed consent, privacy, and the ethical sourcing of biological materials complicate the industry landscape. It is crucial to navigate the legal and societal implications associated with this technology, including matters of animal welfare, to promote responsible innovation and sustainable practices within the market. Addressing these ethical dilemmas is essential for fostering public trust and ensuring that the development of organ-on-chip technologies aligns with societal values and norms, ultimately influencing their widespread acceptance and application.

Market Trends of the Organ on Chip Market

The Organ-on-Chip market is witnessing a notable trend toward enhancing drug safety and effectiveness predictions amidst the escalating costs and challenges faced by the pharmaceutical industry. As traditional methods prove inadequate, companies are increasingly adopting organ-on-chip technologies to provide more accurate, human-relevant data for drug testing. This innovative approach enables researchers to simulate human organ responses to therapeutic compounds, significantly reducing reliance on animal testing and improving predictive capabilities. Consequently, there is a growing investment in the development of sophisticated organ-on-chip models, which are anticipated to revolutionize the drug discovery process by streamlining research and accelerating time-to-market for new therapies.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Patent Analysis
Case Study Analysis
Trade Analysis
Customer & Buying Criteria Analysis

Global Organ On Chip Market Size by Organ Type & CAGR (2026-2033)

Market Overview
Liver
Kidney
Intestine
Lung
Heart
Other Organs

Global Organ On Chip Market Size by Model Type & CAGR (2026-2033)

Market Overview
Organ-Based Models
Disease-Based Models

Global Organ On Chip Market Size by Product & Service & CAGR (2026-2033)

Market Overview
Services
- Custom Services
- Standard Services
Products
- Instruments
- Consumables & Accessories
- Software

Global Organ On Chip Market Size by Purpose & CAGR (2026-2033)

Market Overview
Therapeutics
Research

Global Organ On Chip Market Size by Application & CAGR (2026-2033)

Market Overview
Toxicology Research
Drug Discovery
Physiological Model Development
Tissue Regeneration & Regenerative Medicine
Stem Cell Research

Global Organ On Chip Market Size by End User & CAGR (2026-2033)

Market Overview
Pharmaceutical And Biotechnology Companies
Cosmetics Industry
Academic & Research Institutes
Other End Users

Global Organ On Chip Market Size & CAGR (2026-2033)

North America (Organ Type, Model Type, Product & Service, Purpose, Application, End User)
- US
- Canada
Europe (Organ Type, Model Type, Product & Service, Purpose, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Organ Type, Model Type, Product & Service, Purpose, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Organ Type, Model Type, Product & Service, Purpose, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Organ Type, Model Type, Product & Service, Purpose, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Emulate, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mimetas B.V.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tissuse GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CN Bio Innovations Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
InSphero
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alveolix AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fluigent
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments